This is a discussion on FDA Safety Changes: Levaquin, NovoLog, Zevalin within the Other Clinical Pharmacy News forum, part of the Industry News and Updates category; The FDA has approved revisions to the safety labeling for levofloxacin (Levaquin), insulin aspart [rDNA origin] injection (NovoLog), and ibritumomab ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
|
|||
|
The FDA has approved revisions to the safety labeling for levofloxacin (Levaquin), insulin aspart [rDNA origin] injection (NovoLog), and ibritumomab tiuxetan injection (Zevalin).
Medscape Medical News More... |